Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Markets: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:Dabrafenib Mesylate,Dabrafenib Mesylate API,Dabrafenib Mesylate In Stock CAS NO CAS 1195768-06-9
Conbott Pharmtech Co.,Ltd. Dabrafenib Mesylate,Dabrafenib Mesylate API,Dabrafenib Mesylate In Stock CAS NO CAS 1195768-06-9
Home > Products > API > Dabrafenib Mesylate, CAS 1195768-06-9
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

Dabrafenib Mesylate, CAS 1195768-06-9

Share to:  
    Payment Type: T/T,L/C
    Min. Order: 1 Gram
    Delivery Time: 10 Days

Basic Info

Model No.: 1195768-06-9

Additional Info

Packaging: AS Required

Productivity: Customized

Brand: Conbottpharm

Transportation: Ocean,Air

Place of Origin: China

Supply Ability: Commercial


Product Description

CAS 1195768-06-9,High Purity Dabrafenib Mesylate

We are professional 1195768-06-9, High Purity Dabrafenib Mesylate manufacturers and suppliers in China. These high quality products are formulated by adopting quality methods and using well-tested ingredients that are procured from the certified vendors of the market. We offer these products in proper packaging of diverse quantity to meet assorted requirements of the clients.

Thera. Category: Anti- cancer

Cas No.: 1195768-06-9

Synonym: Dabrafenib Mesylate(GSK-2118436B);Dabrafenib Mesylate;GSK 2118436 Mesylate;GSK 2118436B;GSK2118436 Mesylate;GSK-2118436 Mesylate;Dabrafenib Mesylate (API);GSK 2118436 methanesulfonate salt


Molecular Formula:C24H24F3N5O5S3

Molecular Weight: 615.6680696

Assay: ≥97.%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

Usage: Dabrafenib, also known as GSK2118436, is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations. On May 29, 2013, FDA approved this drug.

Related Intermediates :
1. CAS 630-22-8,2,2,2-Trimethylthioacetamide

Looking for ideal Dabrafenib Mesylate Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Dabrafenib Mesylate API are quality guaranteed. We are China Origin Factory of Dabrafenib Mesylate In Stock CAS NO CAS 1195768-06-9. If you have any question, please feel free to contact us.

Product Categories : API

Product Images
  • Dabrafenib Mesylate, CAS 1195768-06-9
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2020 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?